Resverlogix Corp. (RVXCF)
OTCMKTS · Delayed Price · Currency is USD
0.0679
-0.0088 (-11.42%)
Feb 12, 2026, 1:04 PM EST
Resverlogix Market Cap
Resverlogix has a market cap or net worth of $20.05 million as of February 12, 2026. Its market cap has increased by 67.97% in one year.
Market Cap
20.05M
Enterprise Value
108.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 15.78M to 20.05M, an increase of 27.04%. That is a compound annual growth rate of 1.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 23.29M | 11.05% |
| Dec 31, 2025 | 20.97M | 94.88% |
| Dec 31, 2024 | 10.76M | -25.40% |
| Dec 29, 2023 | 14.43M | -47.46% |
| Dec 30, 2022 | 27.46M | -71.96% |
| Dec 31, 2021 | 97.92M | -43.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZIVO Bioscience | 40.77M |
| Cell Source | 38.23M |
| Harvard Apparatus Regenerative Technology | 31.65M |
| Oncotelic Therapeutics | 28.70M |
| EOM Pharmaceuticals Holdings | 22.63M |
| Finch Therapeutics Group | 22.08M |
| Zeo ScientifiX | 18.66M |
| Provectus Biopharmaceuticals | 18.45M |